Thu.Jun 27, 2024

article thumbnail

Walgreens to Close Significant Number of Stores in Continued Erosion of Pharmacy Landscape

Drug Topics

“Retail pharmacy is central to our future and to our overall customer and patient experience. It enables many other things, but it has to change,” said Walgreens CEO Tim Wentworth.

163
163
article thumbnail

STAT+: Supreme Court rejects Purdue bankruptcy plan

STAT

The U.S. Supreme Court rejected a controversial bankruptcy deal in which the owners of Purdue Pharma sought to contribute up to $6 billion in exchange for immunity from further lawsuits. The ruling means the company and its creditors — numerous states, cities and counties, as well as Native American governments — will have to negotiate a new settlement.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Examining the Role of Remote CGM in Diabetes Management

Drug Topics

Two posters presented at the American Diabetes Association 84th Scientific Sessions looked at challenges of remote CGM in older populations and after discharge from the hospital.

Hospitals 162
article thumbnail

By the numbers: America’s alcohol-related health problems are rising fast

STAT

In the pit of the pandemic, with no one to see and nowhere to go, and horrors unfolding daily outside the front door, there was for many a reliable bright spot: the 5 p.m. drink that would mark the end of the workday. Drinking, which was already on the rise before 2020, became a coping mechanism for overburdened parents, burnt-out workers, the traumatized, and the bored.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Quiz: Understanding Migraine Therapies

Drug Topics

Test your knowledge of migraine therapies.

154
154
article thumbnail

During Drug Shortages, There Are Resources so Pharmacists ‘Never Need to Ration Life-Saving Drugs’

Pharmacy Times

Laura Bray, founder of Angels for Change, explains that addressing the 4 key economic causes to drug shortages can also help lead to effective solutions long-term.

145
145

More Trending

article thumbnail

Expert: Having Conversations and Practicing Cultural Competency With LGBTQIA+ Patients

Pharmacy Times

HOPA’s DEI Advisory Board Chair discusses how creating safe environments, using correct pronouns, and being willing to talk about patients’ mental and physical needs are significant when providing care to LGBTQIA+ patients.

139
139
article thumbnail

Q&A: Lessons from the HHS secretary who ran Bush’s bird flu response

STAT

WASHINGTON — Mike Leavitt is in the small club of government officials who’ve led an avian flu response. The experience is still fresh in his mind nearly two decades later. When he first heard about the avian flu outbreak in 2005, he had been secretary of health and human services in George W. Bush’s administration for just a couple of months.

143
143
article thumbnail

Public Health Matters: Generative AI and the Future of Pharmacy

Pharmacy Times

Tune into this episode of “Public Health Matters” to hear Dr. Bolu Oladini’s unconventional journey within pharmacy, his passion for mental health, and how artificial intelligence is beginning to be integrated into health care and everyday life.

139
139
article thumbnail

STAT+: Trying to outrun her prion disease, researcher creates powerful epigenetic editor in mice

STAT

Sonia Vallabh always thought genome editing wouldn’t be an option. It was such an obvious solution that people invariably asked, “What about CRISPR?” at the end of talks. But the details never made sense. Vallabh and her husband, Eric Minikel, scientists at the Broad Institute, have been racing to develop a treatment for prion disease, a rare form of neurodegeneration that killed her mother at age 51 and would, if left untreated, likely kill Vallabh as well.

142
142
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA Issues Complete Response Letter for the Patritumab Deruxtecan BLA Submission

Pharmacy Times

A biologics license application (BLA) for patritumab deruxtecan receives complete response letter due to inspection findings at third-party manufacturer.

FDA 123
article thumbnail

Opinion: To get basic standard addiction treatment, Americans should move to Canada

STAT

As a Canadian-born physician who has treated people with opioid use disorder on both sides of the U.S.-Canada border, I know that if I ever needed addiction treatment I’d head to the Great White North. Deaths from drug overdoses are twice as high in the U.S. as in Canada. Some of that difference stems from how people with opioid use disorder are treated in the two countries.

139
139
article thumbnail

Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections

PharmaVoice

Neuroscience pipelines are reawakening as biotechs prove to the pharma giants that the field is still worth the investment.

122
122
article thumbnail

Opinion: Eating rocks: The case for early integration of medical ethics into AI product development

STAT

Google’s recent integration of Gemini, its state-of-the-art large language model, into its search engine marks a significant step in AI-driven responses for digital health queries. Worldwide, users search Google with health queries 70,000 times per minute , so it has years of experience in communicating health information and a solid framework for producing high quality, authoritatively sourced responses for users.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

A methodological approach in patient insights to discover the emotional patient journey

pharmaphorum

Explore a methodological approach for discovering the emotional patient journey through patient insights. Understand the importance of emotional connections in healthcare.

119
119
article thumbnail

STAT+: Are expensive whole-body MRI scans medically useful? A new clinical trial aims to find out

STAT

A startup selling elective whole-body scans for upward of $1,000 is launching a 10-year, 100,000 person study to attempt to settle doubts within the medical community about its value and potential consequences. Prenuvo, the Redwood City, Calif.-based startup touted last year by Kim Kardashian , is one of a handful of companies selling preventive MRI scans: images that aim to catch conditions like cancer, brain aneurysms, autoimmune disorders, and metabolic issues before they advance.

Insurance 128
article thumbnail

Billionaire Sackler family can't get legal immunity as part of Purdue bankruptcy deal, Supreme Court rules

Fierce Pharma

Years of negotiations and legal proceedings surrounding a high-dollar opioid settlement for Purdue Pharma have reached a dead end at the U.S. Supreme Court. | Years of negotiations and legal proceedings surrounding a high-dollar opioid settlement for Purdue Pharma have reached a dead end at the U.S. Supreme Court.

article thumbnail

Listen: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate

STAT

Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy? And what health care issues may be lightening rods in this election? STAT chief Washington correspondent Rachel Cohrs Zhang joins the podcast to talk about a new proposal for obesity drug coverage in Washington and what to expect from the first presidential debate. STAT health tech reporter Brittany Trang also guest co-hosts “The Readout LOUD” this week, where we discuss AI for drug development, the la

125
125
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Power launch excellence with generative AI

pharmaphorum

Unleash the power of generative AI (GenAI) in the pharmaceutical industry to achieve excellence in product launch strategies. Learn how this cutting-edge technology can drive your business forward.

118
118
article thumbnail

STAT+: Q&A: Defining responsible AI in health care, with CHAI CEO Brian Anderson

STAT

BEVERLY HILLS, Calif. — Artificial intelligence is increasingly infused into many aspects of health care, from transcribing patient visits to detecting cancers and deciphering histology slides. While AI has the potential to improve the drug discovery process and help doctors be more empathetic towards patients, it can also perpetuate bias , and be used to deny critical care to those who need it the most.

125
125
article thumbnail

In bispecific rivalry, AbbVie’s Epkinly follows Roche’s Lunsumio into follicular lymphoma

Fierce Pharma

With Regeneron’s treatment delayed, AbbVie is expanding its T-cell engager competition against Roche in blood cancer with a new FDA approval. | With Regeneron's treatment delayed, AbbVie is expanding its T-cell engager competition against Roche in blood cancer with a new FDA approval.

FDA 115
article thumbnail

Hospital at home program is waiting on Congress, but this New Jersey hospital isn’t

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Hospital at home creeps towards commercial New Jersey-based  Hackensack Meridian Health  this week  announced it will gradually expand its hospital at home program from three of its larger facilitates, to its entire system of 18 hospitals, illustrating growing

Hospitals 120
article thumbnail

Verona’s first-in-class COPD drug ‘could transform market’

pharmaphorum

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster.The first-in-class dual phosphodiesterase (PDE) 3/4 inhibitor – now given the somewhat tongue-twisting brand name of Ohtuvayre – is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years, according to Verona.

FDA 114
article thumbnail

Exclusive: European VC Forbion hires Dyne CEO, expands into US

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Read on today for some exclusive hiring news and a retraction of a high-profile paper on cancer detection.

FDA 114
article thumbnail

FDA Approves Ensifentrine for Treatment of COPD

Drug Topics

The first-in-class selective dual PDE3 and PDE4 inhibitor from Verona Pharma is the first inhaled product with a novel mechanism of action approved to treat COPD in over 20 years.

FDA 112
article thumbnail

Enhancing Pharmacy Practice: Accessible and Affordable Continuing Education for Technicians

Pharmacy Times

New initiatives are tackling historically limited access to free or affordable courses

110
110
article thumbnail

FDA turns down MSD, Daiichi Sankyo HER3 ADC for lung cancer

pharmaphorum

FDA rejects MSD, Daiichi Sankyo’s HER3-targeted ADC patritumab deruxtecan because of problems at a third-party manufacturer

FDA 109
article thumbnail

JPMorgan: How health insurance premiums are impacting small businesses

Fierce Healthcare

Health insurance premiums are putting major pressure on small businesses, according to a new analysis from the JPMorganChase Institute. | Health insurance premiums are putting major pressure on small businesses, according to a new analysis from the JPMorganChase Institute.

Insurance 105
article thumbnail

McKesson, Independent Pharmacy Cooperative Reach Drug Supply Agreement

Pharmaceutical Commerce

The deal offers member pharmacies two pricing options, which will take effect Aug. 1.

article thumbnail

Purdue’s bankruptcy plan in tatters as SCOTUS says no

pharmaphorum

SCOTUS rejects bankruptcy deal that would settle opioid litigation against Purdue Pharma, but also protect the Sackler family from liability.

105
105
article thumbnail

6 CoQ10-rich foods

The Checkup by Singlecare

Coenzyme Q10, also known as ubiquinol or CoQ10, is an antioxidant that the human body naturally produces. It’s present in all human tissues and organs but is most concentrated in the heart, liver, kidneys, pancreas, and skeletal muscle. CoQ10 is essential for your body to maintain healthy tissues and organs. Additionally, research shows it neutralizes free radicals and may help treat or prevent diseases, particularly heart disease.

Hospitals 105
article thumbnail

FDA reveals diversity action plan guide for clinical trials

pharmaphorum

FDA reveals diversity action plan guide for clinical trials Phil.

FDA 105
article thumbnail

Pharma Pulse 6/27/24: Pharmacy Deserts & Underserved/Rural Communities, GoodRx Launches New “Prescription Cost Tracker” & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

101
101